Pursuant to Regulation 30 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 and with reference to Board meeting dated August 29, 2019, Lasa Supergenerics has informed that allotment committee of the Board of Directors of the company have allotted 1,78,08,219 equity shares of company to the promoter of the company. In-principal approval under regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 received from the exchanges through their letter dated November 07, 2019 and November 29, 2019 respectively.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1490.05 |
Dr. Reddys Lab | 5998.60 |
Cipla | 1490.00 |
Zydus Lifesciences | 1047.30 |
Lupin | 1602.45 |
View more.. |